Sort
23,748 grants matching “melanoma”
Genetics of Common Cancers: Discovery to Implementation
$99,835Rosalie Griffin · Mayo Clinic Rochester · K00 · FY2022 · CA
Isoaspartyl Modified Tumor Antigens for Vaccination
$99,829L2 Diagnostics, Llc · R41 · FY2004 · CA
SMC/MUC4-ErbB2 Complex: Implications on Neoplasia
$99,792University Of Miami School Of Medicine · K01 · FY2003 · CA
Cancer Center Support Grant
$99,769Harold E Varmus · Sloan-Kettering Inst Can Research · P30 · FY2009 · CA
aAPC-Mediated NKT cell Modulation to Enhance Cancer Immunotherapy
$99,730Tonya J. Webb · University Of Maryland Baltimore · K01 · FY2012 · CA
Cancer Center Support Grant
$99,705William L. Carroll · New York University School Of Medicine · P30 · FY2009 · CA
ANTIMETASTATIC EFFECT OF THROMBOSPONDIN DERIVED PEPTIDES
$99,619Inkine Pharmaceutical Company, Inc. · R41 · FY2001 · CA
Administrative Core
$99,545Steven R Tannenbaum · Massachusetts Institute Of Technology · P01 · FY2009 · CA
Rapid Case Ascertainment
$99,516Andrew Olshan · Univ Of North Carolina Chapel Hill · P30 · FY2016 · CA
Spectroscopic Home-Detection of Melanoma
$99,513Scientific Solutions, Inc. · R43 · FY2004 · CA
Personalized Clinical Diagnostics and Beyond: Integrated Ring Resonator Arrays
$99,500Ryan C Bailey · University Of Illinois At Urbana-Champaign · DP2 · FY2009 · OD
Mapping inter-cellular trophoblast-decidual signaling to its effects on invasion related maternal-fetal diseases
$99,400Yasir Suhail · University Of Connecticut Storrs · K99 · FY2023 · HD
Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface
$99,353Melody A Swartz · University Of Chicago · R01 · FY2025 · CA
TRANSFECTANT INFLUENZA VIRUSES IN CANCER THERAPY
$99,349Mount Sinai School Of Medicine Of Nyu · R29 · FY2002 · CA
MCJ function in mouse mammary tumor properties
$99,328Mercedes R. Rincon · University Of Vermont & St Agric College · R21 · FY2009 · CA
Defining tumor and blood-based immunogenomic signatures predicting response to immunotherapy in ovarian cancer
$99,171Kelsey R Monson · Icahn School Of Medicine At Mount Sinai · K00 · FY2025 · CA
Rapid Case Ascertainment
$98,923Andrew Olshan · Univ Of North Carolina Chapel Hill · P30 · FY2017 · CA
Mechanisms driving acute and chronic kidney function decline after immune checkpoint inhibitor therapy for cancer
$98,752Meghan E. Sise · Massachusetts General Hospital · R01 · FY2024 · DK
CANCER AND LEUKEMIA GROUP B
$98,655University Of California San Diego · U10 · FY2000 · CA
Administrative Core
$98,623Steven R Tannenbaum · Massachusetts Institute Of Technology · P01 · FY2012 · CA
Signaling Pathways for UV-Induced Melanogenic Response
$98,490Zalfa Abdel-Malek · University Of Cincinnati · R01 · FY2009 · ES
Sun Safe Workplaces: A Campaign on Sun Protection Policies for Outdoor Workers
$98,444David B Buller · Klein Buendel, Inc. · R01 · FY2012 · CA
Defining the role of metabolic heterogeneity in melanoma dissemination and therapy escape
$98,371Inna Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · K99 · FY2019 · CA
Defining the role of metabolic heterogeneity in melanoma dissemination and therapy escape
$98,371Inna Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · K99 · FY2018 · CA
Studies of Benign and Malignant Thyroid Disease
$98,344Joanna Klubo-Gwiezdzinska · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK